Related references
Note: Only part of the references are listed.Beneficial and harmful effects of antidepressants versus placebo, 'active placebo', or no intervention for adults with major depressive disorder: a protocol for a systematic review of published and unpublished data with meta-analyses and trial sequential analyses
Sophie Juul et al.
SYSTEMATIC REVIEWS (2021)
The trouble with antidepressants: why the evidence overplays benefits and underplays risks-an essay by John B Warren
John B. Warren
BMJ-BRITISH MEDICAL JOURNAL (2020)
Vaccines to prevent COVID-19: a protocol for a living systematic review with network meta-analysis including individual patient data (The LIVING VACCINE Project)
Steven Kwasi Korang et al.
SYSTEMATIC REVIEWS (2020)
Should antidepressants be used for major depressive disorder?
Janus Christian Jakobsen et al.
BMJ EVIDENCE-BASED MEDICINE (2020)
Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults
Diana M. Sobieraj et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2019)
Efficacy and tolerability of pharmacological and non-pharmacological interventions in older patients with major depressive disorder: A systematic review, pairwise and network meta-analysis
Marc Krause et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2019)
Newer-Generation Antidepressants and Suicide Risk in Randomized Controlled Trials: A Re-Analysis of the FDA Database
Michael P. Hengartner et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2019)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Decreased suicide rates in recent antidepressant clinical trials
Arif Khan et al.
PSYCHOPHARMACOLOGY (2018)
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Spencer L. G. James et al.
LANCET (2018)
Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study
Delphine Saragoussi et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2018)
Industry sponsorship and research outcome
Andreas Lundh et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
When and how should multiple imputation be used for handling missing data in randomised clinical trials - a practical guide with flowcharts
Janus Christian Jakobsen et al.
BMC MEDICAL RESEARCH METHODOLOGY (2017)
Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis
Janus Christian Jakobsen et al.
BMC PSYCHIATRY (2017)
Efficacy and tolerability of antidepressants in people aged 65 years or older with major depressive disorder - A systematic review and a meta-analysis
Anne Tham et al.
JOURNAL OF AFFECTIVE DISORDERS (2016)
Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports
Tarang Sharma et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Reporting of Adverse Events in Published and Unpublished Studies of Health Care Interventions: A Systematic Review
Su Golder et al.
PLOS MEDICINE (2016)
Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports
Tarang Sharma et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Empirically derived criteria cast doubt on the clinical significance of antidepressant-placebo differences
Joanna Moncrieff et al.
CONTEMPORARY CLINICAL TRIALS (2015)
The Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)
Paul E. Greenberg et al.
JOURNAL OF CLINICAL PSYCHIATRY (2015)
Comparative Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in Older Adults: A Network Meta-Analysis
Kristian Thorlund et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2015)
What has serotonin to do with depression?
Philip J. Cowen et al.
WORLD PSYCHIATRY (2015)
Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence
Joanna Le Noury et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence
Joanna Le Noury et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Quality of life in major depressive disorder before/after multiple steps of treatment and one-year follow-up
W. W. IsHak et al.
ACTA PSYCHIATRICA SCANDINAVICA (2015)
The safety and efficacy of vortioxetine for acute treatment of major depressive disorder: a systematic review and meta-analysis
Amanda S. Meeker et al.
SYSTEMATIC REVIEWS (2015)
The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method
Joanna IntHout et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods
Janus Christian Jakobsen et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
Differences in reporting serious adverse events in industry sponsored clinical trial registries and journal articles on antidepressant and antipsychotic drugs: a cross-sectional study
Shannon Hughes et al.
BMJ OPEN (2014)
Coding of adverse events of suicidality in clinical study reports of duloxetine for the treatment of major depressive disorder: descriptive study
Emma Maund et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Benefits and harms in clinical trials of duloxetine for treatment of major depressive disorder: comparison of clinical study reports, trial registries, and publications
Emma Maund et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Estimation and testing of binomial and beta-binomial regression models with and without zero inflation
James W. Hardin et al.
STATA JOURNAL (2014)
Trend in SSRI-SNRI antidepressants prescription over a 6-year period and predictors of poor adherence
Elisabetta Poluzzi et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Exercise for depression
Jane Rimer et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Impact of document type on reporting quality of clinical drug trials: a comparison of registry reports, clinical study reports, and journal publications
Beate Wieseler et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
A systematic review of duloxetine and venlafaxine in major depression, including unpublished data
Y-B. Schueler et al.
ACTA PSYCHIATRICA SCANDINAVICA (2011)
Cross-national epidemiology of DSM-IV major depressive episode
Evelyn Bromet et al.
BMC MEDICINE (2011)
GRADE guidelines: 9. Rating up the quality of evidence
Gordon H. Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
National Trends in the Treatment for Depression From 1998 to 2007
Steven C. Marcus et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
ANXIETY DOES NOT PREDICT RESPONSE TO DULOXETINE IN MAJOR DEPRESSION: RESULTS OF A POOLED ANALYSIS OF INDIVIDUAL PATIENT DATA FROM 11 PLACEBO-CONTROLLED TRIALS
J. Craig Nelson
DEPRESSION AND ANXIETY (2010)
Use of duloxetine in patients with an anxiety disorder, or with comorbid anxiety and major depressive disorder: a review of the literature
Michele Mancini et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
Antidepressant Drug Effects and Depression Severity A Patient-Level Meta-analysis
Jay C. Fournier et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
ANNALS OF INTERNAL MEDICINE (2009)
Treatment of Depression in the Elderly: A Review of the Recent Literature on the Efficacy of Single- Versus Dual-Action Antidepressants
Yuki Mukai et al.
CLINICAL THERAPEUTICS (2009)
The General and Comparative Efficacy and Safety of Duloxetine in Major Depressive Disorder A Systematic Review and Meta-Analysis
Gerald Gartlehner et al.
DRUG SAFETY (2009)
Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration
Marc Stone et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses
Jesper Brok et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis
Jorn Wetterslev et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
Initial severity and antidepressant benefits: A meta-analysis of data submitted to the food and drug administration
Irving Kirsch et al.
PLOS MEDICINE (2008)
Duloxetine - A review of its use in the treatment of major depressive disorder
James E. Frampton et al.
CNS DRUGS (2007)
Duloxetine - Meta-analyses of suicidal behaviors and ideation in clinical trials for major depressive disorder
Nayan Acharya et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2006)
Duloxetine for the treatment of major depressive disorder: A closer look at efficacy and safety data across the approved dose range
Craig H. Mallinckrodt et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2006)
Duloxetine and venlafaxine-XR in the treatment of major depressive disorder: A meta-analysis of randomized clinical trials
PMJ Vis et al.
ANNALS OF PHARMACOTHERAPY (2005)
Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors
FP Bymaster et al.
NEUROPSYCHOPHARMACOLOGY (2001)
Completeness of safety reporting in randomized trials - An evaluation of 7 medical areas
JPA Ioannidis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
